OraSure Technologies has officially cut the ribbon on Opus Way, its new expanded facility in Bethlehem Township, which was constructed with the help of $109 million from the U.S. Department of Defense (DOD) to ramp up production of InteliSwab COVID-19 rapid tests as part of the nation’s pandemic preparedness plan. 

OraSure Technologies Inc of Bethlehem has a new president and CEO. 

OraSure Technologies Inc. Of Bethlehem has appointed Dr. Nancy Gagliano, MD to serve as interim CEO starting April 1.  

The company, which makes tests for diseases such as HIV and COVID-19, said that CFO Roberto Cuca has resigned from the company with his last day being Sept.17. 

The U.S. Food & Drug Administration is requesting more information on the lab-based oral COVID-19 test being developed by OraSure Technologies.

OraSure Technologies has developed a saliva collection device that’s been included in an FDA emergency authorization grant to a Syracuse medical diagnostic development company for COVID-19 lab testing.

OraSure said the support from BARDA will help it complete development of the ELISA and file for Emergency Use Authorization from the Food & Drug Administration to enter the U.S market.